[PDF] from hindawi.comH Chunchao… - Evidence-based Complementary …, 2011 - downloads.hindawi.com Hindawi Publishing Corporation Evidence-Based Complementary and Alternative Medicine Volume 2011, Article ID 252501, 3 pages doi:10.1093/ecam/neq037 ... Active Compound Modulates Immunity and Increases Survival in ... 1 School of Pharmacy, Shandong University of ... Related articles - View as HTML - All 4 versions
[HTML] from plos.orgL Opatowski, C Fraser, J Griffin, E de Silva… - PLoS Pathogens, 2011 - dx.plos.org Although relatively mild, the 2009 H1N1 pandemic reminded us once again of the on-going threat posed by novel respiratory viruses and the need for understanding better how such pathogens emerge and spread. From April to September 2009, countries in temperate regions of the ... Cached
AE Fiore, A Fry, D Shay, L Gubareva… - … and reports: Morbidity …, 2011 - ncbi.nlm.nih.gov This report updates previous recommendations by CDC's Advisory Committee on Immunization Practices (ACIP) regarding the use of antiviral agents for the prevention and treatment of influenza (CDC. Prevention and control of influenza: recommendations of the Advisory Committee ... Cited by 6 - Related articles
D Corti, J Voss, SJ Gamblin, G Codoni… - Science, 2011 - sciencemag.org ... A Neutralizing Antibody Selected from Plasma Cells That Binds to Group 1 and Group 2 Influenza A Hemagglutinins. ... The isolation of broadly neutralizing antibodies against influenza A viruses has been a long-sought goal for therapeutic approaches and vaccine design. ... Cited by 1
[PDF] from floridashealth.comJ Skarbinski, S Jain, A Bramley… - Clinical Infectious …, 2011 - cid.oxfordjournals.org Given the potential worsening clinical severity of 2009 pandemic influenza A (H1N1) virus (pH1N1) infection from spring to fall 2009, we conducted a clinical case series among patients hospitalized with pH1N1 infection from September through October 2009. A case patient ... Cited by 1 - Related articles - All 3 versions